Back to Journals » Research and Reports in Urology » Call For Papers
Research and Reports in Urology
ISSN: 2253-2447
The following Article Collection/ Thematic Series is currently open for submissions:
Focal Therapy in Prostate Cancer: Advances and Clinical Applications
Dove Medical Press is pleased to announce a new Article Collection in Research and Reports in Urology, dedicated to the transformative role of focal therapy in the management of prostate cancer. Since its clinical introduction, focal therapy has revolutionized patient care, offering benefits in preserving urinary and sexual function, minimizing treatment-related morbidity, and enabling targeted cancer control.
Given the importance of focal therapy in managing prostate cancer, Research and Reports in Urology invites submissions of original research articles, reviews, and perspectives exploring the clinical efficacy, safety, mechanisms of action, and real-world application of these paradigm-shifting therapies.
This collection, edited by Editor-in-Chief Professor Panagiotis J Vlachostergios, is part of the new Game Changer series of Article Collections, spotlighting breakthrough therapies that redefine standards of care and deliver game-changing improvements in patient outcomes.
While the call welcomes manuscripts across the broad spectrum of focal therapy in prostate cancer, the Editors are particularly interested in submissions addressing the following priority areas:
- Patient selection and biomarkers: advances in MRI-guided targeting, genomic profiling, and risk stratification for focal therapy candidacy.
- Energy modalities and technologies: comparative outcomes of HIFU, cryotherapy, laser ablation, and irreversible electroporation.
- Long-term oncologic outcomes: disease-free survival, recurrence patterns, and integration with active surveillance protocols.
- Complications and side effects: Short-term (urinary retention, infection) vs. long-term risks (erectile dysfunction), management strategies for adverse events.
- Technological advancements: AI in treatment planning and imaging interpretation, robotics/real-time imaging integration and nanotechnology, combination therapies (e.g., focal ablation + immunotherapy)
Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.
All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.
The deadline for submissions is 1 April 2026.
Please submit your manuscript on our website, quoting the promo code BICXO for a 20% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.
Call For Papers
Editor-in-Chief: Dr Panagiotis Vlachostergios
To see where Research and Reports in Urology is indexed online view the Journal Metrics
What is the advantage to you of publishing in Research and Reports in Urology?
- It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
- Unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
- The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Research and Reports in Urology has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
- Many authors have found that our peer reviewer’s comments substantially add to their final papers.
To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.
PubMed Central
Research and Reports in Urology is indexed on PubMed Central (title abbreviation: Res Rep Urol). All published papers in this journal are submitted to PubMed for indexing straight away.
Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.
Yours sincerely
Dr Panagiotis Vlachostergios
Editor-in-Chief
Research and Reports in Urology
Email: Editor-in-Chief
Updated 11 October 2022